In VivoEfficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models

Synthesis and Spectrum of the Neoglycoside ACHN-490

(2010) J. B. Aggen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

(2010)   CLINICAL INFECTIOUS DISEASES

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)

(2009) Paul R. Rhomberg et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria

(2008) Katherine E. Kollef et al.   CHEST

Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities

(2008) Carl Urban et al.   CLINICAL INFECTIOUS DISEASES

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Carbapenem-Resistant Enterobacteriaceae

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High Rates of Plasmid-Mediated Quinolone Resistance QnrB Variants Among Ciprofloxacin-Resistant Escherichia coli and Klebsiella pneumoniae from Urinary Tract Infections in Korea

(2008) Jeong Hwan Shin et al.   Microbial Drug Resistance